| Today's Open | $1.57 |
|---|---|
| Previous Close | $1.56 |
| Daily Range | $1.50 - $1.58 |
| 52-Week Range | $0.46 - $5.50 |
| Market Cap | $205.7M |
| P/E Ratio | -5.38 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,414,643 |
| Average Daily Volume | 3,167,311 |
| Current FY EPS | -$0.23 |
Sector
Healthcare
Industry
Drugs
Peregrine Pharmaceuticals (PPHM) Description
A biopharmaceutical company with a portfolio of clinical stage and pre-clinical product candidates using monoclonal antibodies for the treatment of cancer and viral diseases. Website: http://www.peregrineinc.com/
News & Commentary
Why Peregrine Pharmaceuticals Shares Popped
Peregrine delivers positive data at the American Society of Clinical Oncology's annual meeting and gets rewarded by shareholders.
Taking a page out of the old West, it was a mix of the good, the bad, and the ugly this week in the biotech sector.
Encouraging News for Peregrine Pharma - Analyst Blog
Encouraging News for Peregrine Pharma - Analyst BlogEncouraging News for Peregrine Pharma - Analyst Blog
Encouraging News for Peregrine Pharma - Analyst BlogFDA Green Light = Surprise Share Surge
Did this FDA decision really justify a big stock pop?These Winners Couldn't Send the Dow to Another Record
The Dow fell slightly, but several stocks posted solid gains.PPHM's Top Competitors
(-3.85%)
(2.44%)
(1.78%)
(1.47%)